The present and future of nanotechnology in human health care

被引：538

作者：

Sahoo, S. K. ^{[1
]}

Parveen, S. ^{[1
]}

Panda, J. J. ^{[1
]}

机构：

[1] Nanomed Lab, Inst Life Sci, Bhubaneswar, Orissa, India

来源：

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE | 2007年 / 3卷 / 01期

关键词：

nanotechnology; nanomedicine; drug delivery; nanodiagnostic; molecular imaging; LUMINESCENT QUANTUM DOTS; MEDIATED GENE-TRANSFER; DRUG-DELIVERY; MACROMOLECULAR THERAPEUTICS; DENTINAL TUBULES; CLINICAL-TRIALS; NANOPARTICLES; THERAPY; CELLS; P53;

D O I：

10.1016/j.nano.2006.11.008

中图分类号：

TB3 [工程材料学];

学科分类号：

0805 ; 080502 ;

摘要：

Nanotechnology is a multidisciplinary field that covers a vast and diverse array of devices derived from engineering, physics, chemistry, and biology. The burgeoning new field of nanotechnology, opened up by rapid advances in science and technology, creates myriad new opportunities for advancing medical science and disease treatment in human health care. Applications of nanotechnology to medicine and physiology imply materials and devices designed to interact with the body at subcellular (i.e., molecular) scales with a high degree of specificity. This can be potentially translated into targeted cellular and tissue-specific clinical applications designed to achieve maximal therapeutic efficacy with minimal side effects. In this review the chief scientific and technical aspects of nanotechnology are introduced, and some of its potential clinical applications are discussed. (c) 2007 Elsevier Inc. All rights reserved.

引用

页码：20 / 31

页数：12

共 141 条

[1] DENTIN HYPERSENSITIVITY - A STUDY OF THE PATENCY OF DENTINAL TUBULES IN SENSITIVE AND NON-SENSITIVE CERVICAL DENTIN [J].

ABSI, EG ;

ADDY, M ;

ADAMS, D .

JOURNAL OF CLINICAL PERIODONTOLOGY, 1987, 14 (05) :280-284

[2]

Addy M, 1994, Curr Opin Periodontol, P71

[3] Nanocrystal targeting in vivo [J].

Åkerman, ME ;

Chan, WCW ;

Laakkonen, P ;

Bhatia, SN ;

Ruoslahti, E .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (20) :12617-12621

[4] Supramolecular structures from dendrons and dendrimers [J].

Al-Jamal, KT ;

Ramaswamy, C ;

Florence, AT .

ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (15) :2238-2270

[5] The use of nanocrystals in biological detection [J].

Alivisatos, P .

NATURE BIOTECHNOLOGY, 2004, 22 (01) :47-52

[6] Drug delivery systems: Entering the mainstream [J].

Allen, TM ;

Cullis, PR .

SCIENCE, 2004, 303 (5665) :1818-1822

[7] Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study [J].

Alyautdin, RN ;

Tezikov, EB ;

Ramge, P ;

Kharkevich, DA ;

Begley, DJ ;

Kreuter, J .

JOURNAL OF MICROENCAPSULATION, 1998, 15 (01) :67-74

[8]

[Anonymous], 2005, ASIA PACIFIC BIOTECH

[9] Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics [J].

Arangoa, MA ;

Campanero, MA ;

Renedo, MJ ;

Ponchel, G ;

Irache, JM .

PHARMACEUTICAL RESEARCH, 2001, 18 (11) :1521-1527

[10] Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines [J].

Arbós, P ;

Campanero, MA ;

Arangoa, MA ;

Irache, JM .

JOURNAL OF CONTROLLED RELEASE, 2004, 96 (01) :55-65

← 1 2 3 4 5 6 7 8 9 10 →